This chemotactic factor attracts monocytes and basophils but not neutrophils or eosinophils and augments monocyte anti-tumor activity. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. It may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.

Target

MCP1

Species

Human

Positive Controls

Form Supplied

Lyophilized powder

Purification

Purified

Purification Note

Sterile filtered. Greater than 98% pure by SDS-PAGE and HPLC analyses. Endotoxin level is less than 0.1 ng per µg (1EU/µg).

Concentration

1
mg/ml
(Please refer to the vial label for the specific concentration)

Storage Instruction

Prior to reconstitution store at 4°C. Following reconstitution keep as concentrated solution, aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Notes

For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.